WTR Small-Cap Spotlight

Send us Fan MailIn this Showcase Series, Rob Spillman, Chairman and CEO of Bassett Furniture Industries (NASDAQ: BSET), joins host Doug Lane, Managing Director and Consumer Analyst at WTR, to discuss how one of America’s oldest furniture brands is driving growth in a challenging housing environment. Spillman walks through Bassett’s “good, better, best” product strategy and the opening‑price‑point introductions that stood out at High Point Market, the expansion of the Lane Venture outdoor brand into Bassett retail stores, the company’s blend of U.S. manufacturing with complementary overseas sourcing, and the newly opened Cincinnati store marking a return to a key market. With nearly 125 years of history behind it, Bassett is leaning on innovation, lean operations, and long‑term confidence in the American home furnishings market.

Send us Fan MailIn this episode of WTR Small-Cap Spotlight, Oren Hershkovitz, CEO of Enlivex, joins host Tim Gerdeman, Vice Chair, Co-Founder, and CMO of Water Tower Research, along with Dr. John Roy, WTR’s Senior Equity Research Analyst. The conversation explores the evolved corporate strategy of Enlivex, a clinical-stage immunotherapy company that has pioneered a dual-pillar approach combining traditional drug development with a high-exposure digital asset treasury (DAT). Unlike companies that focus their treasuries on Bitcoin, Enlivex is the first public company to center its strategy around prediction markets, specifically the RAIN decentralized protocol. This novel approach allows the company to potentially leverage yield enhancement activities from its digital assets to aggressively fund the clinical development of its lead immunotherapy candidate, Allocetra, currently in late-stage trials for age-related osteoarthritis.

Send us Fan MailExoZymes (NASDAQ: EXOZ) CEO Michael Heltzen joins Tim Gerdeman and Robert Sassoon in this episode of the WTR Small-Cap Spotlight podcast to discuss the company’s AI-driven, cell-free biomanufacturing platform and how it aims to overcome longstanding scalability challenges in synthetic biology. The conversation covers the scientific differentiation of its “exozyme” enzyme engineering approach, the commercial strategy behind its lead programs in metabolic health (NCT) and non-intoxicating cannabinoids, and the broader opportunity to produce high-value molecules that have historically been inaccessible at scale. The podcast also explores regulatory dynamics, near-term commercialization milestones, and ExoZymes’ dual strategy of advancing internal assets while positioning the platform for future licensing, alongside considerations around capital efficiency and funding.

Send us Fan MailIn this episode of WTR Small-Cap Spotlight, Brian Mehler, CEO of Stable, joins host Tim Gerdeman, Vice Chair, Co-Founder, and CMO of Water Tower Research, along with Dr. John Roy, WTR’s Senior Equity Research Analyst. The conversation explores the strategic priorities of Stable, an institutional-grade Layer 1 blockchain purpose-built for stablecoin transactions and global payments. Unlike many general-purpose chains that use volatile gas tokens, Stable is USDT-native, meaning it uses USDT as its native gas token to ensure predictable transaction costs and a stable $1 peg for fees. This approach removes the friction caused by market swings, which can often make transactions on other networks 15% to 20% more expensive during periods of volatility.

Send us Fan MailIn this episode of WTR Small‑Cap Spotlight, Douglas Hineline, Tech Lead and Senior Platform Engineer at Arrive AI (NASDAQ: ARAI), joins WTR’s Tim Gerdeman and James Kisner to discuss how Arrive AI is building the infrastructure layer for autonomous last‑mile delivery. Hineline breaks down how Arrive Points—the company’s smart lockers and mini cross‑docks—act as secure exchange hubs linking drones, ground robots, couriers, retailers, and consumers. The conversation explores Arrive AI’s early traction in healthcare and campus logistics, why advances in AI, edge compute, robotics, and drone regulation are accelerating market readiness, and how the company aims to “own the last inch of the last mile” through a broader Network‑as‑a‑Service platform.

Send us Fan MailJoin WTR's Tim Gerdeman and Peter Gastreich as they unpack key takeaways from WTR's Circular Economy Symposium (Part 1 – SAF) — and lay out why investors should be paying close attention to this sector right now — including high-level feedback from conversations with Kline + Company and CEOs from leading SAF companies or their subsidiaries (AGIG, CLMT, LODE, SAFX). Topics include: the persistent expected structural gap between mandated demand and available supply; why regulatory tailwinds are potentially the most favorable the industry has ever experienced; why the Strait of Hormuz crisis is pulling long-term demand forward and reshaping the energy security case for domestic SAF; and what separates the winners from the losers — including the critical importance of feedstock strategy and how carbon intensity directly impacts the value of SAF.

Send us Fan Mail In this episode of WTR Small Cap Spotlight, Al Petrie, Founder and Senior Partner at Al Petrie Advisors, joins Tim Gerdeman, Richard Tullis, and Jeff Robertson of Water Tower Research to preview what sets the Louisiana Energy Conference apart. They discuss the conference’s independent structure, all-panel format, broad industry reach, and why this year’s agenda—covering offshore and onshore E&P, oil services, LNG, carbon capture, infrastructure, power generation, and data center demand—offers a timely cross-section of today’s energy landscape. www.louisianaenergyconference.com

Send us Fan MailJohn Passalacqua, CEO of First Phosphate, joins host Tim Gerdeman and WTR’s Dmitry Silversteyn to break down the strategic significance of the €170M loan guarantee from a European government entity and its impact on advancing the company’s flagship Canadian project. 

Send us Fan MailThis WTR Symposium Series podcast is the first of a three-part symposium exploring investment opportunities emerging from industrial decarbonization and the circular resource economy. The first episode focuses on sustainable aviation fuel (SAF). Our keynote speaker from Kline + Company, and senior leadership from Abundia Global Impact Group (AGIG), Bioleum Corp (Comstock) (LODE), Montana Renewables (Calumet) (CLMT), and XCF Global (SAFX) join the Water Tower Research team including Shawn Severson, CEO and Co-founder, and Peter Gastreich, Managing Director - Energy and Sustainable Investing, to discuss how waste streams become jet fuel, which SAF business models generate real returns, strong regulatory tailwinds, and why energy security is rewriting the renewable fuels investment thesis. 

Send us Fan MailWater Tower Research's healthcare equity analyst Robert Sassoon breaks down President Trump's executive order on therapeutic psychedelics, examining the five key mechanisms it puts in place — from accelerated FDA review vouchers and right-to-try expansion to federal funding and ibogaine pathway clearance. Sassoon explains what the order gets right, where it falls short (namely on reimbursement and rescheduling), and which companies — including Compass Pathways, Dephinium Therapeutics, and Helus Pharma — stand to benefit most as the sector gains its first clear federal endorsement as a legitimate therapeutic class. 

Send us Fan MailIn this episode of the WTR Small-Cap Spotlight podcast, Tal Jacobson, CEO of Perion Network (NASDAQ: PERI), joins host Tim Gerdeman and WTR's James Kisner to discuss how the repositioned, AI-native Perion is tackling fragmentation in the trillion-dollar digital ad market. Jacobson walks through Perion One — a platform that sits above ad-buying platforms like Google, YouTube, Meta, and TikTok rather than replacing them — and Outmax, the company's AI agent that applies algorithmic-trading methodology to media buying for 52 Fortune 100 companies. Because Perion owns no inventory, it can recommend shifting spend to whichever channel delivers the best outcome — an edge single-channel players can't match. The conversation covers Q4 momentum, growth in CTV, Digital Out-of-Home, and Retail Media, partnerships with Amazon, Walmart Connect, and Mastercard, and a three-year plan targeting 20%+ organic ex-TAC CAGR, 28% EBITDA margins by 2028, and $300M+ in cash.

Send us Fan MailOn this episode of the WTR Small-Cap Spotlight, Gary Atkinson, CEO of Algorhythm Holdings (NASDAQ: RIME), joins host Tim Gerdeman and WTR’s James Kisner. The discussion centers on SemiCab, the company’s AI-driven collaborative optimization platform built to reduce empty truck miles and improve freight network efficiency by turning one-off shipments into continuous, multi-stop flows. Atkinson highlights accelerating managed-services traction with major consumer brands in India, the real-world operating benefits the platform has delivered for customers, and the longer-term opportunity to expand into the U.S. through the higher-margin APEX SaaS offering. The conversation also covers growth milestones for 2026, the advantages of the company’s asset-light model, and how management is thinking about scaling the business while funding continued expansion.

Send us Fan MailIn this special edition of the WTR Small‑Cap Spotlight Flashcast, Water Tower Research CEO and Co‑Founder Shawn Severson previews the WTR Insights Virtual Conference, April 14–15. The two‑day event features 24 small‑ and micro‑cap companies across ALL WTR research sectors. These companies represent more than $5.5B in combined market cap and will give investors direct access to C-Suite management through fireside chats,  one‑on‑one and small group meetings. Severson explains what sets this conference apart: analyst‑led conversations focused on strategy, competitive positioning, and the business drivers that matter. He also covers the open‑access format, available company primers, and how investors can follow up after the event.

Send us Fan MailOn this episode of the WTR Small‑Cap Spotlight, James Kisner, Technology Analyst at Water Tower Research, joins Tim Gerdeman, Vice Chair, Co‑Founder, and Chief Marketing Officer of Water Tower Research, to discuss the latest insights from WTR’s suite of AI research products. Kisner walks through key themes from the newest AI Flow Newsletter, describing what he calls a “whiplash” month — from viral bear‑case essays and a 4,000‑person layoff explicitly citing AI, to OpenAI’s record‑breaking $110B capital raise and the Pentagon’s unprecedented supply‑chain risk designation for Anthropic.He also breaks down the AI Flow Index, which tracks the stock performance of roughly 400 public companies and shows a striking five‑month divergence: semiconductors up nearly 60% since launch while software has declined about 26%. Kisner then introduces the new AI Flow Private Pools Newsletter, which tracks approximately 45 private AI companies with a combined market value of about $1.73 trillion, highlighting notable valuation shifts — including Anthropic’s standout $92 billion single‑month gain.

Send us Fan MailRobert Sassoon, WTR Senior Healthcare Analyst, joins Tim Gerdeman to discuss obstructive sleep apnea (OSA) and the rapidly evolving treatment landscape for this widespread yet often undiagnosed and potentially fatal condition. The conversation explores the shift away from CPAP amid high non‑adherence rates toward emerging alternatives, including neurostimulation, pharmacotherapy, and oral appliances. Sassoon also highlights the valuation gap between incumbents such as ResMed (NYSE: RMD) and innovators like Vivos Therapeutics (NASDAQ: VVOS), whose approach extends beyond symptom management to address finite anatomical correction.

Send us Fan MailIn this episode, 1‑800‑Flowers.com CFO James Langrock and SVP of Investor Relations Andy Milevoj join Water Tower Research Managing Director Doug Lane and host Tim Gerdeman for a deep dive into the company’s multi‑year transformation under new CEO Adolfo Villagomez. The discussion explores the leadership overhaul, the shift from a brand‑led to a functional organizational structure, and renewed priorities around marketing efficiency, customer retention, and technology modernization.From its beginnings as a single Manhattan flower shop in 1976 to its evolution into a $1.7 billion e‑commerce gifting platform serving 9 million customers, the conversation examines how 1‑800‑Flowers is working to restore profitable growth, expand into third‑party marketplaces and retail channels, leverage data and AI to enhance personalization, and build on a business where roughly 74% of revenue comes from repeat customers.

Send us Fan MailIn this episode of WTR Small-Cap Spotlight, Dr. Raza Bokhari, Executive Chairman and CEO of Medicus Pharma (NASDAQ: MDCX), joins Tim Gerdeman and Robert Sassoon to walk through the company’s strategy and market focus. Dr. Bokhari explains how Medicus Pharma acquires mid‑stage drug assets with existing data, reducing development risk and positioning the company for potential partnerships with larger pharmaceutical players.The conversation highlights Medicus Pharma’s two lead programs aimed at major, established markets—including treatments for skin cancer and prostate‑related conditions, both representing large patient populations and significant commercial demand. Dr. Bokhari also discusses how the company is using generative AI to speed decision‑making, along with upcoming milestones and opportunities to secure non‑dilutive funding through out‑licensing.

Send us Fan MailIn this episode of the Small-Cap Spotlight, we welcome back Dr. Amit Kumar, Chairman and CEO of Anixa Biosciences (NASDAQ: ANIX) who explains why 2026 is shaping up to be a pivotal year for the company. Building on the momentum of 2025, Dr. Kumar walks us through key developments across Anixa’ clinical pipeline and strategic direction. He outlines the company’s plans as its breast cancer vaccine progresses into Phase 2 following strong Phase 1 results. At the same time, he emphasizes the striking efficacy signals emerging from the Phase 1 study of Lira‑Cel, Anixa’ CAR‑T therapy for ovarian cancer, observed in a terminally ill patient population. Dr. Kumar also details key protocol enhancements in the ongoing Phase 1 trial, to help steer the program toward potentially groundbreaking curative outcomes. Finally, supported by Anixa’s capital‑efficient business model, Dr. Kumar notes that the expansion of clinical data in 2026 could drive meaningful opportunities for pharma partnerships and further validate the company’s broader immunotherapy strategy.

Send us Fan MailDmitry Silversteyn, WTR’s Chemicals & Materials Analyst, and Tim Gerdeman discuss the key themes emerging from the 2026 PDAC conference and the growing attention the critical elements mining and processing industry is receiving from investors and governments seeking to reduce reliance on China‑controlled supply chains.

Send us Fan MailOn this week’s episode of the WTR Small-Cap Spotlight, Matt Edelman, CEO and Chairman of Super League Enterprise (NASDAQ: SLE), joined Tim Gerdeman, Vice Chair & Co-Founder and Chief Marketing Officer of Water Tower Research, and James Kisner, Technology Analyst at Water Tower Research. Super League helps brands reach gaming audiences through scalable ad products and interactive experiences inside platforms like Roblox, Fortnite, and Minecraft, and applies play-driven behavioral insights to drive advertising performance across digital video, social media, and connected TV. Edelman walks through the company’s successful recapitalization, which eliminated all debt and positioned the business to scale, and highlights recent brand campaigns with Google and Panda Express. He describes how recent acquisitions and partnerships are consolidating gamer data into a unified intelligence platform, and discusses growing operating momentum heading into 2026 as the company targets sustainable profitability.

Send us Fan MailIn this episode of the WTR Small‑Cap Spotlight Video Podcast (recorded on 3/9/2026), members of the Water Tower Research Energy Team — Jeff Robertson, Richard Tullis, and Chris Degner — join host Tim Gerdeman to break down the rapid surge in oil prices following escalating geopolitical tensions in the Middle East.With elevated oil prices and disruptions affecting shipping through the Strait of Hormuz — a corridor that typically handles about 20% of global oil flows — the team examines how supply interruptions, strategic petroleum reserve releases, and OPEC dynamics may shape energy markets in the weeks ahead.They also explore how quickly U.S. shale producers could respond, why gasoline prices are rising so rapidly, what the oil futures curve is signaling about tightening supply, and which segments of the energy sector may be best positioned if elevated prices persist.

Send us Fan MailIn this episode of the Small‑Cap Spotlight podcast, Jeff Robertson, WTR Natural Resources Analyst, joins Tim Gerdeman, Vice Chair, Co‑Founder, and Chief Marketing Officer of Water Tower Research, to break down how small‑ and mid‑cap producers are navigating the latest oil spike and rising uncertainty. Jeff explains how companies are maintaining stable production plans, prioritizing cash returns, and accelerating deleveraging despite the volatility.

Send us Fan MailIn this episode of the WTR Healthcare Happenings, Adam Fraser, COO of Omniscient Neurotechnology—a privately held, Australian‑based but U.S.-focused company pioneering AI‑driven brain mapping—joins Water Tower Research Co‑Founder Tim Gerdeman and Healthcare Analyst Robert Sassoon for a deep dive into the future of clinical connectomics. The discussion explores how Omniscient’s flagship platform, Quicktome, uses advanced AI to transform complex brain data into intuitive, Google‑Maps‑style network visualizations that enhance neurosurgical planning, support coma and mental‑health assessments, and inform broader brain‑care decisions. Fraser also walks through the company’s growth trajectory, funding milestones, and strategy to scale across the U.S. hospital market while laying the groundwork for global expansion and broader neurotech partnerships. The conversation concludes with Omniscient’s long‑term vision to build a comprehensive “brain data economy” capable of powering next‑generation innovations—from BCIs and DBS to emerging solutions like TMS for major psychiatric conditions.

Send us Fan MailJoin Dmitry Silversteyn, Managing Director – Chemicals & Materials Technology Analyst, and Tim Gerdeman, WTR Vice Chair, Co‑Founder, and Chief Marketing Officer, as they discuss the potential impact of the Middle East conflict on the chemicals and materials industry over the short to medium term.

Send us Fan MailBassett Furniture (NASDAQ: BSET) Chairman & CEO Rob Spilman and CFO Mike Daniel join host Tim Gerdeman of Water Tower Research to discuss the company’s evolution into a leader in customized home furnishings. They discuss Bassett’s restructuring mindset, fast domestic manufacturing, product innovation across upholstery and case goods, and growth opportunities as independent furniture retailers consolidate.

Send us Fan MailIn this WTR Small Cap Spotlight episode, Richard Tullis breaks down why oil & gas still dominate the global energy mix—and how AI data-center power demand is reshaping the next decade. With markets re-pricing geopolitical risk after the Iran conflict and threats to traffic through the Strait of Hormuz, Richard explains what’s moving crude and natural gas right now—and how he builds his monthly price outlook. 

Send us Fan MailWater Tower Research Co-founder Tim Gerdeman and Managing Director Dmitry Silversteyn were joined by Mayo Schmidt, Executive Chairman of Brazil Potash Corp. to discuss the strategic importance, development progress, and logistics-driven cost advantages of the Autazes Potash Project as Brazil seeks greater fertilizer self-sufficiency.

Send us Fan MailIn this episode of the WTR Healthcare Happenings podcast, Rick Pierce, CEO of Decoy Therapeutics (NASDAQ: DCOY), joins Tim Gerdeman, Vice Chair, Co‑Founder, and CMO of Water Tower Research, and Robert Sassoon, WTR’s Healthcare Research Analyst. The conversation explores Decoy’s innovative business model for developing peptide‑conjugate antivirals designed to target multiple respiratory viruses. Pierce discusses how Decoy is navigating the modern era of drug development with a cost‑effective, highly efficient strategy that positions the company as a disruptive force in biotech. Central to this approach is Decoy’s proprietary peptide‑synthesis technology and rapid design‑build‑test cycle, powered by machine learning. He also highlights the importance of Decoy’s strategic partnerships with the Gates Foundation, Google, and NVIDIA in advancing its platform and accelerating development.

Send us Fan MailOn this week’s episode of the WTR Small-Cap Spotlight, Peter Flippo, Director, Business Development, at Avantium R&D Solutions (Euronext Amsterdam: AVTX-NL) (US OTC: AVTXF), joined Tim Gerdeman, Vice Chair & Co-Founder and Chief Marketing Officer of Water Tower Research, and Peter Gastreich, Energy and Sustainable Investing Analyst at Water Tower Research.  Avantium is a technology company founded in 2000 as a Shell spin-out, specializing in innovative chemical solutions. It operates two main segments: Renewable Polymers, which develops sustainable plastics, and R&D Solutions (RDS), which provides high-throughput catalyst testing systems and services for clients worldwide—including oil & gas firms, refineries, and research institutions. Flippo discusses how Avantium’s Flowrence technology significantly accelerates R&D timelines from years to months, offering reliable, scalable, and cost-effective testing. He shared how the company is positioned as a valuable partner in the high-growth sustainable aviation fuel (SAF) industry by optimizing catalytic processes and enabling the use of multiple SAF production pathways.

Send us Fan MailJoin Tim Gerdeman, Vice Chair & Co-Founder and Chief Marketing Officer at WTR, and Peter Gastreich, Senior Energy Transition and Sustainability Analyst, as they break down WTR’s latest deep-dive report on Gevo including financial forecasts. Gevo is a leading renewable fuels and chemicals company focused on producing low-carbon alternatives to fossil fuels, including low-carbon ethanol, sustainable aviation fuel (SAF), and renewable natural gas. Its integrated carbon strategy features biogenic CO₂ capture and permanent storage, digital carbon tracking via the Verity platform, and modular Alcohol-to-Jet (ATJ) technology. The North Dakota Red Trail acquisition added a profitable ethanol plant, a large and scalable carbon capture system, and prime location for ATJ (SAF) expansion. In the longer-term, third-party CCS and ATJ-30 technology sales are significant drivers. 

Send us Fan MailIn this episode of the WTR Small‑Cap Spotlight, Harrison Gross, CEO of Innovative Eyewear (NASDAQ: LUCY), joins host Tim Gerdeman and technology analyst James Kisner for a deep dive into the future of smart eyewear. Innovative Eyewear develops prescription, safety, and sport smart glasses—and introduced the world’s first smart glasses powered by ChatGPT. Gross explains how voice‑based AI has transformed smart glasses from simple Bluetooth audio devices into always‑on AI interfaces, creating a natural upgrade path for the billion people who already wear glasses.The discussion explores the company’s 65% year‑over‑year revenue growth in 2025, driven by the breakout success of the ANSI‑certified Lucyd Armour smart safety glasses; its competitive moat built on roughly 110 patents and a cross‑disciplinary team with experience from Bose and Luxottica; and how its focus on wearability and prescription readiness differentiates it from Meta’s camera‑centric approach. Looking ahead, Gross highlights retail distribution as the primary growth lever for 2026, with big‑box retailer discussions underway and a new white‑label business unit in development. 

Send us Fan MailIn this episode of WTRSmall-Cap Spotlight, Patrick Horsman Chief Investment Officer and Josh Kruger Founder of BNB Plus (Nasdaq ticker symbol BNBX), joins host Tim Gerdeman, Vice Chair, Co-Founder, and CMO of Water Tower Research, along with Dr. John Roy, WTR’s Technology Research Analyst. The conversation explores the digital asset treasury company and its focuse on the Binance ecosystem and its native BNB token. The team explains that they chose BNB for its unique status as a deflationary asset tied to the world's largest crypto exchange, offering investors indirect exposure to Binance’s earnings through token burns and "launch pool" air drops. Utilizing their hedge fund backgrounds, the leadership employs four non-directional yield strategies—including staking and automated market making—to target a 9% to 12% annual return for shareholders while mitigating downside risk.

Send us Fan MailOn this week’s episode of the WTR Small-Cap Spotlight, Corrado De Gasperis, Chief Executive Officer of Comstock Inc. (NYSE: LODE), joined Tim Gerdeman, Vice Chair & Co-Founder and Chief Marketing Officer of Water Tower Research, and Peter Gastreich, Energy and Sustainable Investing Analyst at Water Tower Research. De Gasperis discusses Comstock’s high-volume, zero‑landfill solar panel recycling platform, which recovers 100% of panel materials, including significant amounts of silver, aluminum, and other critical minerals. He outlines the structural shift underway in the silver market driven by accelerating industrial demand from solar, electrification, and advanced technologies, and explains how Comstock is positioned to capture value through recycling economics that blend environmental service fees, low operating costs, and commodity sales. With its first permitted facility in Nevada commissioning, plans to scale multiple recycling sites nationwide, and a strategy to vertically integrate domestic silver refining, Comstock is positioned for strong cash flow growth and long-term leadership in sustainable metals. 

Send us Fan MailIn this episode of the WTR Small-Cap Spotlight Podcast, American Outdoor Brands President & CEO Brian Murphy and CFO Andy Fulmer join host Tim Gerdeman, Vice Chair & Co-Founder and Chief Marketing Officer of Water Tower Research, and Doug Lane, Consumer Analyst at Water Tower Research, to discuss the company’s innovation-driven strategy and growth momentum heading into 2026. The conversation explores disruptive product launches such as the expanding Claycopter platform, American Outdoor Brands’ unique approach to identifying and solving market contradictions, and the growing success of brands including MEAT! Your Maker and Grilla. Management also shares perspectives on tariff mitigation, international expansion opportunities, and how gamification and subscription models are reshaping customer engagement across fishing, hunting, shooting, and outdoor cooking. 

Send us Fan MailIn this episode of the WTR Small-Cap Spotlight, host Tim Gerdeman and technology analyst James Kisner are joined by Nikolas Bullwinkel, Founder and CEO of Circus SE (Frankfurt: CA1). Bullwinkel previously co-founded quick commerce company Flink, scaling it to a multi-billion Euro valuation before launching Circus to bring full autonomy to the trillion-dollar food service industry. The CA-1 robot replaces entire canteen operations in hospitals, airports, and corporate environments—producing 100 meals per hour with integrated AI, sensors, and the proprietary Circus OS software platform. Bullwinkel highlights the company's razor-blade business model, with each robot adding approximately €100k in annual recurring revenue. Defense applications are accelerating as armed forces seek to modernize logistics infrastructure, with Circus's container-based CA-M deploying in minutes versus hours for traditional field kitchens. With 800,000 meals tested, 40 patents, production partner Celestica ramping capacity, and an order book exceeding 500 units, Bullwinkel characterizes 2026 revenue guidance of €44-55M as conservative and outlines a long-term vision for building a global nutrition intelligence platform.

Send us Fan MailOur guest for this Flashcast edition is Shawn Severson, CEO and Co-Founder of Water Tower Research, and Head of Market Commentary and Thematic Research. Shawn breaks down his latest research, “The Cost of Equity Pivot: Why Structure Now Matters More Than Rates,” which challenges the traditional small-cap playbook heading into 2026. While falling interest rates have helped fuel a recent rebound in small caps, Shawn explains why the true driver of the innovation economy in 2026 is the cost of equity, not the cost of debt. He outlines the market’s structural shift from “survival financing” to “growth financing,” why markets are now rewarding solvency over dilution, and how investors should position around clean cap tables, funded innovators, and a barbell strategy as the small-cap equity window reopens.

Send us Fan MailOn this week's episode of the WTR Small-Cap Spotlight, Benjamin Slager, Chief Executive Officer and Chairman of Blue Biofuels (US OTC: BIOF), joined Tim Gerdeman, Vice Chair & Co-Founder and Chief Marketing Officer of Water Tower Research, and Peter Gastreich, Energy and Sustainable Investing Analyst at Water Tower Research. Slager details the company’s innovative CTS technology, which transforms non-food plant material into cellulosic ethanol and sustainable aviation fuel (SAF). Slager highlights the process’s efficiency, low costs, and major carbon reductions compared to corn ethanol. Blue Biofuels is launching its first commercial plant in Florida and partnering with Vertimass LLC for SAF production. With strong market demand, abundant feedstock and cost leadership, Blue Biofuels is positioned for profitability and long-term growth.

Send us Fan MailOur guest for this episode is Rick Rosenthal, Director of Business Development at Cboe Global Markets (Cboe: CBOE), where he focuses on helping advisors and wealth managers utilize options-based strategies. He joins Tim Gerdeman, Vice Chair, Co-Founder, and Chief Marketing Officer of Water Tower Research, for a timely discussion on derivatives positioning in the U.S. small-cap market.Rick explains why Russell 2000 (RUT) options have become a go-to vehicle for gaining or hedging small-cap exposure, highlighting structural advantages versus IWM, rising zero-DTE retail activity, and how investors are using protective puts, spreads, and volatility-harvesting strategies. The conversation also explores macro drivers behind the rotation into small caps, volatility signals from the RVX index, and Cboe’s plan to expand RUT trading to Global Trading Hours in 2026, introducing new access points for both institutional and retail participants.____

Send us Fan MailIn this episode of the WTR Small-Cap Spotlight, host Tim Gerdeman and healthcare analyst Robert Sassoon are joined by Dr. Jim Gilligan, President and Chief Science Officer of Entropy Neurodynamics (ASX: ENP), formerly Tryptamine Therapeutics. Dr. Gilligan explains the motivation behind the company’s rebrand and its decision to prioritize three core therapeutic targets: Binge Eating Disorder, Fibromyalgia, and Irritable Bowel Syndrome/abdominal pain. Although Entropy has reported positive Phase 2a results using oral psilocybin across these indications, Dr. Gilligan outlines why the company is shifting its strategy toward developing proprietary IV‑delivered psilocin formulations combined with psychotherapy, beginning with binge eating disorder. The discussion also covers Entropy’s work on real‑time EEG and brain entropy as a potential biomarker, the company’s financing,  regulatory roadmap, and longer‑term expansion opportunities in areas such as PTSD.

Send us Fan MailIn this special Flashcast episode of the WTR Small-Cap Spotlight podcast, Tim Gerdeman sits down with WTR Healthcare analyst Robert Sassoon to discuss his Initiation of Coverage Report on Anixa Biosciences. Their conversation explores Anixa’s two clinical‑stage programs—one, an innovative CAR‑T cell therapy for terminal ovarian cancer patients, and the other, a breast cancer vaccine designed for both treatment and prevention. They review Phase 1 results, upcoming 2026 milestones, and how Anixa differentiates itself through both its scientific platforms and disciplined financial management.

Send us Fan MailIn this episode of the WTR Small Cap Spotlight Podcast, LifeVantage President & CEO Steve Fife and Chief Sales Officer Kristen Cunningham join Water Tower Research to discuss the company’s “Breakthrough Era” and strategic priorities for 2026. The conversation covers the successful integration of Love Biome, growing consultant engagement, new science-backed product innovation, and enhanced digital tools designed to drive customer activation and retention. Management also shares insights on upcoming live events and how LifeVantage is positioning itself for sustainable growth in the year ahead. 

Send us Fan MailJoin Tim Gerdeman, Vice Chair & Co-Founder and Chief Marketing Officer at WTR, and Peter Gastreich, Senior Energy Transition and Sustainability Analyst, as they unpack WTR’s Initiation of Coverage report for Abundia Global Impact Group (NYSE American: AGIG). AGIG's waste-to-value approach converts hard-to-recycle plastics and waste wood into sustainable aviation fuel (SAF), diesel, and more.  AGIG stands out through proven, scalable modular technologies, a prime Houston Shipping Channel location, and strategic partnerships. In terms of sustainability, AGIG both helps to decarbonize transportation and divert waste from landfills. Peter highlights 2026 milestones like site expansion, commercialization steps, and EBITDA scenarios. 

Send us Fan MailIn this episode, WTR’s Tim Gerdeman is joined by Forum Energy Technologies (NYSE: FET) President & CEO Neal Lux and EVP & CFO Lyle Williams, along with WTR analyst Jeff Robertson, to unpack the company’s FET 2030 strategy and how it builds on FET’s “Beat the Market” playbook.

Send us Fan MailIn this special Flashcast episode of the WTR Small-Cap podcast, Tim Gerdeman and WTR Healthcare analyst Robert Sassoon break down why more than 90% of biotech companies listed on a U.S. exchange choose NASDAQ over the NYSE.

Send us Fan MailJoin Tim Gerdeman, Vice Chair & Co-Founder and Chief Marketing Officer at WTR, and Peter Gastreich, Senior Energy Transition and Sustainability Analyst, as they dive into WTR’s Initiation of Coverage report for Comstock Inc. (NYSE: LODE), a Nevada-based innovator tackling clean energy and industrial bottlenecks. Discover how Comstock’s businesses are driving growth include its cutting-edge solar panel recycling (metals business), historic mining assets, strategic real estate, and renewable fuels (Bioleum subsidiary). Get insights on the outlook for silver, aluminum, and sustainable aviation fuel (SAF), and learn why these are important to the outlook for LODE. Peter also discusses project economics and shares WTR’s financial forecasts for LODE including its rapid EBITDA growth to 2030. 

Send us Fan MailOn this week's episode of the WTR Small-Cap Spotlight, Arthur Sams, President, CEO and Chairman of the Board of Polar Power (NASDAQ ticker POLA), joined Tim Gerdeman, Vice Chair & Co-Founder and Chief Marketing Officer of Water Tower Research, and Peter Gastreich, Energy and Sustainable Investing Analyst at Water Tower Research. Sams highlights the company's innovative DC power and cooling solutions, which offer substantial fuel savings and reliability for telecom, EV charging, and microgrid applications. POLA is actively diversifying its revenue sources beyond telecom into residential, industrial, and military markets, leveraging its engineering expertise and production capacity. The company is tackling supply chain and tariff challenges by manufacturing most components in-house and adapting quickly to market changes. Sams points to a growing backlog, new product launches, and strategic partnerships as key drivers for future growth and mainstream adoption over the next 12 to 18 months.

Send us Fan MailIn this episode of WTR Small-Cap Spotlight, host Tim Gerdeman and analyst Robert Sassoon speak with Eric Poma PhD, CEO of Calidi Biotherapeutics Inc (NYSE American: CLDI).  The discussion focuses on how Calidi is solving the "delivery problem" in cancer treatment, and specifically how to transport cancer-killing oncolytic viruses systemically through the bloodstream without the body’s immune system neutralizing them before they reach the tumor.

Send us Fan MailOn this week's episode of the WTR Small-Cap Spotlight, Philipp Stratmann, CEO of Ocean Power Technologies (NYSE: OPTT), joined Tim Gerdeman, Vice Chair & Co-Founder and Chief Marketing Officer of Water Tower Research, and Peter Gastreich, Energy and Sustainable Investing Analyst at Water Tower Research. OPT is rapidly advancing maritime domain awareness with autonomous solutions for defense, energy, and research. Stratmann spotlights OPT’s breakthrough $5 million DHS contract for its game-changing first multi-buoy deployment, emphasizing deep integration with Coast Guard systems on the Pacific Coast. Leveraging unique, self-recharging buoys, OPT stands apart from competitors and is expanding its pipeline with more multi-asset, recurring contracts. With momentum in defense and security contracts related to the U.S. maritime border and strategic growth overseas, Stratmann is bullish on OPT’s outlook.

Send us Fan MailTune in to the latest WTR Small-Cap Spotlight Flashcast! Join Tim Gerdeman, Vice Chair & Co-Founder and Chief Marketing Officer at WTR, and Peter Gastreich, Senior Energy Transition and Sustainability Analyst, as they discuss Peter’s recent report and: 1) concerns from scientists about over-reliance on carbon capture and storage (CCS) as a climate solution; 2) the benefits of CCS with ethanol and sustainable aviation fuel (SAF); 3) what makes SAF scalable, sustainable, and economically beneficial; 4) other viable pathways like woody biomass waste and plastics-to-fuel; and 5) related companies including Abundia Global Impact Group (AGIG), Comstock (LODE), Gevo (GEVO), and Green Plains (GPRE).

Send us Fan MailIn this episode of WTR Small-Cap Spotlight, host Tim Gerdeman and analyst Robert Sassoon speak with Dwight Egan, CEO of Co-Diagnostics Inc. (NASDAQ: CODX), about the company’s evolution from a pandemic-era PCR testing provider to a diversified molecular diagnostics leader. In our discussion, Egan highlights the Co-DX PCR Pro, a portable, cost-effective device that delivers gold-standard PCR testing outside the lab and explains how its patented Co-Primer multiplexing technology sets it apart from competitors. Our conversation also covers Co-Diagnostics’ “razor-and-blade” business model, its pipeline of testing capabilities targeting high-impact infectious diseases, the role of AI in manufacturing and diagnostic optimization, and the commercial strategies needed to achieve long-term financial success.